0.0001 (2.04%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Neutral
Earnings
Weak
Earnings
Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Neutral
Website
Solvonis Therapeutics Plc
Telephone
44.77.9543.0246
Address
25 Eccleston Place, Eccleston Yards, Central Working Victoria, London, Greater London SW1W 9NF
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0 - 0
Trade Value (12mth)
US$53,136.00
1 week
2.04%
1 month
-19.35%
YTD
-21.87%
1 year
92.31%
All time high
0.22
EPS 3 yr Growth
-95.40%
EBITDA Margin
0.00%
Operating Cashflow
-£3m
Free Cash Flow Return
-70.60%
ROIC
-123.80%
Interest Coverage
0.00
Quick Ratio
4.00
Shares Outstanding (Fully Diluted)
6,421m
HALO Sector
Discretionary
Next Company Report Date
30-Jun-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
GBP
Short Sell (% of issue)
0.00
| Date | Announcements |
| 05 May 26 | |
| 29 April 26 | |
| 22 April 26 | |
| 20 April 26 | |
| 08 April 26 |
Historical data
Forecast data
| GBP | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | £ |  | | | | -0.03 | N/A | N/A | | | | ||
EPS (Fully Diluted) | £ | | | | | -0.03 | N/A | N/A | | | | ||
Growth | % | | | | | -14.9 | 95.3 | 14.3 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
